GSK to develop pre-pandemic vaccine in Japan
This article was originally published in Scrip
Executive Summary
GlaxoSmithKlineis planning to begin the clinical development of its pre-pandemic flu vaccine Prepandrix in Japan next month, with a view to eventually supplying the product to the government for stockpiling.